|Videos|June 29, 2022

Future Perspectives in Renal Cell Carcinoma (RCC)

Dr Thomas Hutson comments on the TiNivo-2 trial and discusses upcoming and novel therapies for patients with renal cell carcinoma.

Newsletter

Stay up to date on cancer updates, research and education